Drug
Zygk1
Zygk1: highest development phase Phase 1, developed by Zydus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zydus
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZYGK1 NCT01472809 | Phase 1 | Diabetes |
Latest
No recent events.
Follow Zygk1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.